Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
57.50
-1.96 (-3.30%)
At close: Feb 11, 2026, 4:00 PM EST
57.50
0.00 (0.00%)
After-hours: Feb 11, 2026, 7:00 PM EST
Revenue by Geography
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Dec '25 Dec 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | Mar '20 Mar 28, 2020 | Mar '19 Mar 30, 2019 | Mar '18 Mar 31, 2018 | Apr '17 Apr 1, 2017 | Apr '16 Apr 2, 2016 | Mar '15 Mar 28, 2015 | Mar '14 Mar 29, 2014 | Mar '13 Mar 30, 2013 |
|---|
| 978.50M | 1.01B | 970.01M | | | | | | | | | | | |
United States Revenue Growth | -3.21% | 4.22% | 15.08% | | | | | | | | | | | |
| 65.90M | 62.41M | 58.09M | | | | | | | | | | | |
| 5.60% | 7.44% | -5.23% | | | | | | | | | | | |
| 174.40M | 175.66M | 160.14M | | | | | | | | | | | |
| -0.71% | 9.69% | 2.21% | | | | | | | | | | | |
| 88.40M | 92.31M | 107.54M | | | | | | | | | | | |
| -4.23% | -14.16% | 3.27% | | | | | | | | | | | |
| 11.08M | 19.54M | 13.28M | | | | | | | | | | | |
Other Geographic Revenue Growth | -43.30% | 47.09% | 263.62% | | | | | | | | | | | |
| 1.32B | 1.36B | 1.31B | | | | | | | | | | | |
| -3.13% | 3.96% | 12.01% | | | | | | | | | | | |
Revenue Breakdown 2
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Dec '25 Dec 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | Mar '20 Mar 28, 2020 | Mar '19 Mar 30, 2019 | Mar '18 Mar 31, 2018 | Apr '17 Apr 1, 2017 | Apr '16 Apr 2, 2016 | Mar '15 Mar 28, 2015 | Mar '14 Mar 29, 2014 | Mar '13 Mar 30, 2013 |
|---|
| 520.90M | 535.43M | 569.54M | | | | | | | | | | | |
| -2.71% | -5.99% | 13.80% | | | | | | | | | | | |
| 220.86M | 261.12M | 283.23M | | | | | | | | | | | |
Blood Center Revenue Growth | -15.42% | -7.80% | -2.12% | | | | | | | | | | | |
| 576.51M | 564.27M | 456.29M | | | | | | | | | | | |
| 2.17% | 23.66% | 20.65% | | | | | | | | | | | |
| 1.32B | 1.36B | 1.31B | | | | | | | | | | | |
| -3.13% | 3.96% | 12.01% | | | | | | | | | | | |
EBIT
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Dec '25 Dec 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | Mar '20 Mar 28, 2020 | Mar '19 Mar 30, 2019 | Mar '18 Mar 31, 2018 | Apr '17 Apr 1, 2017 | Apr '16 Apr 2, 2016 | Mar '15 Mar 28, 2015 | Mar '14 Mar 29, 2014 | Mar '13 Mar 30, 2013 |
|---|
Plasma Segment Operating Income (Post-Q3 2025 Reporting) | - | 184.51M | 181.97M | | | | | | | | | | | |
Plasma Segment Operating Income (Post-Q3 2025 Reporting) Growth | - | 1.40% | 45.87% | | | | | | | | | | | |
Blood Center Segment Operating Income (Post-Q3 2025 Reporting) | - | 52.82M | 42.37M | | | | | | | | | | | |
Blood Center Segment Operating Income (Post-Q3 2025 Reporting) Growth | - | 24.65% | -34.07% | | | | | | | | | | | |
Hospital Segment Operating Income (Post-Q3 2025 Reporting) | - | 88.98M | 52.20M | | | | | | | | | | | |
Hospital Segment Operating Income (Post-Q3 2025 Reporting) Growth | - | 70.46% | 77.45% | | | | | | | | | | | |
| 251.09M | 221.82M | 164.88M | | | | | | | | | | | |
Operating Income (Total) Growth | 13.20% | 34.53% | 5.67% | | | | | | | | | | | |
EBIT 2
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Dec '25 Dec 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | Mar '20 Mar 28, 2020 | Mar '19 Mar 30, 2019 | Mar '18 Mar 31, 2018 | Apr '17 Apr 1, 2017 | Apr '16 Apr 2, 2016 | Mar '15 Mar 28, 2015 | Mar '14 Mar 29, 2014 | Mar '13 Mar 30, 2013 |
|---|
Plasma Segment Operating Income | - | - | 309.79M | | | | | | | | | | | |
Plasma Segment Operating Income Growth | - | - | 11.20% | | | | | | | | | | | |
Blood Center Segment Operating Income | - | - | 109.56M | | | | | | | | | | | |
Blood Center Segment Operating Income Growth | - | - | -17.07% | | | | | | | | | | | |
Hospital Segment Operating Income | - | - | 184.18M | | | | | | | | | | | |
Hospital Segment Operating Income Growth | - | - | 19.27% | | | | | | | | | | | |
| 251.09M | 221.82M | 164.88M | | | | | | | | | | | |
Operating Income (Total) Growth | 13.20% | 34.53% | 5.67% | | | | | | | | | | | |
Updated Feb 5, 2026. Data Source:
Fiscal.ai.
